ARAF and infection: Although a few infection cases caused by B. thailandensis in immunocompromised patients were reported (Brett et al., 1998; Glass et al., 2006; Chang et al., 2017), it is extensively studied as a model organism of the factors controlling virulence or as a producer of secondary metabolites, such as the metabolite bactobolin produced by a hybrid PKS-NRPS gene cluster (Duerkop et al., 2009; Seyedsayamdost et al., 2010), thailandamide biosynthesized through PKS (Nguyen et al., 2008), and the acyldepsitripeptide histone deacetylase inhibitor burkholdac catalyzed by NRPS (Biggins et al., 2011).